Takeda Pharmaceutical
295 hedge funds and large institutions have $954M invested in Takeda Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 101 increasing their positions, 94 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 298 → 295 (-3)
6% less capital invested
Capital invested by funds: $1.02B → $954M (-$62.2M)
Holders
295
Holding in Top 10
–
Calls
$22.9M
Puts
$496K
Top Buyers
| 1 | +$21M | |
| 2 | +$9M | |
| 3 | +$6.76M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$6.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.32M |
Top Sellers
| 1 | -$66.2M | |
| 2 | -$18.6M | |
| 3 | -$10.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7.07M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$6.1M |